-
-
-
-
-
-
-
BioNTech authorizes $1 billion share repurchase program
-
-
-
-
-
-
-
US Judge blocks Trump Admin cuts to number of routinely recommended vaccines for children - Reuters
-
-
-
-
-
-
-
BioNTech (BNTX) PT Lowered to $128 at BofA Securities
-
-
-
-
-
-
-
BioNTech plans six new phase 3 oncology trials in 2026
-
-
-
-
-
-
-
BioNTech exchange offer for CureVac expires December 3
-
-
-
-
-
-
-
TD Cowen Reiterates Hold Rating on BioNTech (BNTX)
-
-
-
-
-
-
-
Kennedy To Change Childhood Vaccine Schedule In Sept: Monarez - Bloomberg
-
443,917 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

